Triparna Sen (Sen-Lab)
@triparnasen
Followers
3K
Following
9K
Media
327
Statuses
1K
Cancer Researcher|Professor @OSUCCC_James| Associate Director| Advancing therapy of #lungcancer. #SCLC #lineageplasticity #biomarkers & #DDR. Views are my own.
Columbus, Ohio
Joined March 2011
Amazing closing keynote at @IASLC #HT25 by Dr. Charles Swanton @CharlesSwanton on the Early Stage Lung Cancer Ecosystem. Charlie is an amazing speaker and a true leader in the field. Really glad to have him with us. #HT25 @IASLC #LCSM @OncoAlert @oncodaily @lcsmchat
1
1
12
Exciting talk by Dr. Matthew Park of the Icahn School of Medicine at Mount Sinai on myeloid IL-1 signaling driving the precancer to #cancer #evolution of human pulmonary nodules. Impressive mechanistic insights. #HT25 @IASLC #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official
0
0
6
Great session by Dr. Sun Min Lim of Severance Hospital at Yonsei University Health System on #perioperative approaches for non-small cell #lungcancer with #oncogenic addiction. She highlights the challenges and the ongoing efforts in this space. #HT25 @IASLC #LCSM @OncoAlert
0
0
7
Excellent presentation by Dr. Yasushi Yatabe from the National Cancer Center Singapore on #pathologic #response as both an #outcome and #predictor guiding #therapeutic #choices in early-stage #lungcancer. #HT25 @IASLC #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official
0
0
3
Fascinating talk by my conference co-chair, Dr. Aaron Tan from the National Cancer Center Singapore, on biological insights in #neoadjuvant #therapy for #earlystage #lungcancer. #HT25 @IASLC #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official @JLCS_OFFICIAL @OhioStateMedOnc
0
1
10
Engaging and highly informative talk by Dr. Tetsuya Mitsudomi of Kindai University on perioperative strategies for NSCLC without AGA. A true leader in thoracic oncology and an invaluable conference co-chair. #HT25 @IASLC #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official
0
0
5
Exciting data shared by Wei Jie Seow from the National University of Singapore Global Asia Institute on pre-diagnostic circulating metabolites and #lungcancer risk from the #COMETS consortium. Impressive international effort. #HT25 #LCSM @IASLC @OncoAlert @oncodaily @lcsmchat
0
0
3
Insightful talk by Jacky Lam of the Chinese University of Hong Kong on the cell-free fragmentome assay. A compelling step toward #precision #earlydetection. @JackyWKLam
#HT25 #LCSM @IASLC @OncoAlert @oncodaily @lcsmchat @JSMO_official @JLCS_OFFICIAL @OhioStateMedOnc
Fascinating talk from @JackyWKLam showing how fragmentomics (FRAGMA) can be used as a sensitive cancer detection tool. I didn’t realise they developed GRAIL assay, which is not that good for early stage NSCLC! @IASLC #HT25
0
0
2
Great presentation by Fabrizio Bianci from IRCCS Casa Sollievo della Sofferenza Foundation on #circulating #miRNA. Strong promise for early #lungcancer #biomarkers. @IASLC #HT25 #LCSM @IASLC @OncoAlert @oncodaily @lcsmchat @JSMO_official @JLCS_OFFICIAL @OhioStateMedOnc
Fabrizio Bianchi presenting some lovely data using circulating miRNA as a screening tool. Needs small amount of plasma and quite impressive at detecting Stage 1 #NSCLC @iaslc #HT25
0
0
3
Excellent and engaging session by Dr. Ehab Billatos of Boston University on nasal or buccal swap-based detection approaches. Exciting direction for non-invasive screening. #HT25 #LCSM @IASLC @OncoAlert @oncodaily @lcsmchat @JSMO_official @JLCS_OFFICIAL @OhioStateMedOnc
Ehab Billatos on nasal swabs (vericyte) as a predictor for #NSCLC. The low invasiveness is attractive esp if built into screening @IASLC #HT25 #LCSM
0
0
3
Masterclass by Dr. Ming Tsao of Princess Margaret Cancer Centre on histology and molecular #biomarkers for #prognosis in #earlystage #NSCLC. Amazing leadership by Dr. Tsao in this space. #HT25 @IASLC #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official @JLCS_OFFICIAL
0
2
10
Excellent presentation by Jia Tao Zhang from the Guangdong Lung Cancer Institute on the application of #MRD in #earlystage #lungcancer. Clear impact for #clinical translation. @IASLC #HT25 @IASLC #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official @JLCS_OFFICIAL @OhioStateMedOnc
0
0
2
Fantastic talk by Dr. Tom John from the Peter MacCallum Cancer Centre on current and future applications of #liquidbiopsies in #NSCLC. @TommyJohn00
@IASLC #HT25 @IASLC #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official @JLCS_OFFICIAL @OhioStateMedOnc @OhioStateWIMS
0
0
3
Fascinating science from Dr Chaoqiang Deng of Fudan University Shanghai Cancer Hospital on integrative spatial analysis revealing #tumor #heterogeneity and #immune colony niches in small cell lung cancer. @IASLC
#HT25 @IASLC #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official
0
0
1
An excellent and engaging session by Dr. Robert Samstein of Mount Sinai on risk factors associated with #inherited #genes. Strong #science shaping risk assessment. #HT25 #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official @JLCS_OFFICIAL @OhioStateMedOnc @OhioStateWIMS
@rsamstein presenting on the immunological and and hereditary risk of NSCLC initiation. HLA zygosity is implicated in immunotherapy response but also lung cancer risk (mainly Class II). Fascinating data - heterozygosity associated with reduced NSCLC risk and response #HT25 #LCSM
0
1
5
Exciting presentation by Dr. Kenichi Yoshida from the National Cancer Center Research Institute on tobacco smoking and #somatic #mutations in human bronchial epithelium. Clear impact for #lungcancer prevention. #HT25 #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official
0
0
6
Starting the Day 2 with fascinating talk by Dr. Clare Weeden from The Walter and Eliza Hall Institute of Medical Research on occupational and environmental hazards associated with #lungcancer. Important insights for #earlydetection. #HT25 #LCSM @OncoAlert @oncodaily @lcsmchat
0
1
4